遗传毒性
彗星试验
指南
体内
DNA损伤
彗星
化学
生物
遗传学
DNA
医学
内科学
毒性
病理
天体生物学
标识
DOI:10.1007/978-1-0716-0323-9_6
摘要
DNA damage detected by the in vivo comet assay is an initial factor for Clastogenicity and gene mutation, and it is considered that the potential for carcinogenesis can be evaluated. However, there is a problem that the test results were not stable because the results fluctuated largely depending on the test execution conditions. Therefore, the Organisation for Economic Co-operation and Development (OECD) test guideline have described the conditions under which tests should be conducted in order to obtain stable data. Herein, I describe an in vivo comet assay that is based on recently approved the OECD test guideline (TG 489).
科研通智能强力驱动
Strongly Powered by AbleSci AI